Menu

Contineum Therapeutics, Inc. CTNM

Full chart Compare
Set alert

Price alert · CTNM

All alert types
10.30 USD +0.78 (+8.19%)

At closeNov 9, 2026, 4:30 PM EST

10.50 +0.20 +1.94%

After hours · Nov 9, 4:30 PM ET

9.32 Day range 10.50
7.08 52-week range 17.57
YTD
-9.89%
1 year
-5.76%

Revenue & Expenses

Other Income → Gross Profit & Other Income: $39.25MGross Profit & Other Income → Net Income: $22.72MGross Profit & Other Income → Selling, General & Admin: $6.32MGross Profit & Other Income → Research & Development: $27.60MGross Profit & Other Income → Other Operating Expenses: $32.15MGross Profit & Other Income → Income Tax: $450.00KGross Profit → Gross Profit & Other Income: $50.00MRevenue → Gross Profit: $50.00MOther Income$39.25MGross Profit$50.00MGross Profit & Other Income$89.25MNet Income$22.72MSelling, General & Admin$6.32MResearch & Development$27.60MOther Operating Expenses$32.15MIncome Tax$450.00KRevenue$50.00M

Latest period ending Dec 31, 2025 · select a line to chart its full history

CTNM annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
-68.06M-50.89M16.08M-22.72M
-59.98M-42.26M3.15M-24.25M
-2.17-2.180.08-10.81
CTNM annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
75.60M21.94M15.53M5.57M
276.64M212.85M130.39M50.64M
15.65M14.78M5.70M11.37M
8.25M6.26M572.00K5.85M
260.99M198.07M-67.94M-93.21M
CTNM annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022
-55.31M-32.84M19.35M-20.12M
-3.71M-69.74M-65.57M22.30M
112.69M109.00M56.18M-1.24M
-231.00K-494.00K-414.00K-118.00K
53.66M6.42M9.96M939.00K